The McNair Group
McNair Group, based in Houston, Texas, is an investment advisory firm established in 1998, specializing in the energy and real estate sectors. The firm focuses on venture capital investments in technology startups within these industries. In addition to its investment activities, McNair Group offers a range of training and consultative services aimed at enhancing organizational culture and development. The firm is managed by an experienced executive team dedicated to delivering outcomes-based skills through professional coaching and support.
Private Equity Round in 2016
Oseberg will improve people’s lives by enabling them to work effortlessly with data to solve problems.
Xeris Biopharma is a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables. The company’s proprietary XeriSol and XeriJect formulation technologies allow for the subcutaneous (SC) and intramuscular (IM) delivery of highly concentrated, non-aqueous, ready-to-use formulations of peptides, proteins, antibodies, and small molecules using syringes, auto-injectors, multi-dose pens, and infusion pumps. Xeris’ platforms have the potential to offer distinct advantages over existing formulations of marketed and development-stage products. In particular, XeriSol and XeriJect offer the opportunity to eliminate reconstitution, enable long-term room temperature stability, significantly reduce injection volume, and eliminate the requirement for intravenous (IV) infusion. These attributes can lead to products that are easier to use by patients, caregivers, and health practitioners and reduce costs for payers and the healthcare system.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.